Resistance to activated protein C: role in venous and arterial thrombosis
- 31 December 1996
- journal article
- review article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 50 (6-7), 254-260
- https://doi.org/10.1016/0753-3322(96)84822-0
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control studyThe Lancet, 1995
- Mutation in the Factor V Gene and the Risk of Myocardial InfarctionNew England Journal of Medicine, 1995
- Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C.Journal of Clinical Investigation, 1994
- Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutationThe Lancet, 1994
- Evaluation of activated protein C resistance in stored plasmaThe Lancet, 1994
- Bad blood by mutationNature, 1994
- Mutation in blood coagulation factor V associated with resistance to activated protein CNature, 1994
- Activated protein C resistance in deep-vein thrombosisThe Lancet, 1994
- Hereditary deficiency of antithrombin III, protein C and protein SBlood Coagulation & Fibrinolysis, 1992
- Homozygous Protein C Deficiency Manifested by Massive Venous Thrombosis in the NewbornNew England Journal of Medicine, 1984